Koninklijke Philips N.V.
Research Koninklijke Philips N.V. (PHG) on Bullrun: valuation model: 19.9% undervalued, market cap USD 23.69B, P/E 18.1, dividend yield 4.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPHG
- ExchangeNYSE
- CountryNetherlands
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal19.9% undervalued
- Market capUSD 23.69B
- P/E18.1
- Dividend yield4.1%
- Financial periodQ2 2026
- RevenueEUR 4.36B
- Net incomeEUR 384.00M
- Free cash flowEUR 219.00M
- Gross margin49.3%
Valuation Snapshot
Bullrun's latest valuation model marks Koninklijke Philips N.V. as 19.9% undervalued; latest market cap is USD 23.69B; P/E is 18.1; dividend yield is 4.1%.
Peer valuation comparison
Latest P/E is 18.06x versus a Healthcare sector median of 24.61x (26.6% below).
Latest dividend yield is 4.09% versus a Healthcare sector median of 1.84% (122.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 17.83B | EUR 895.00M | EUR 504.00M | 45.2% | 0.94 | EUR 2.79B | EUR 7.81B | EUR 10.96B |
| FY2024 | EUR 18.02B | -EUR 702.00M | EUR 893.00M | 43.1% | -0.75 | EUR 2.40B | EUR 7.49B | EUR 12.01B |
| FY2023 | EUR 18.17B | -EUR 466.00M | EUR 1.49B | 41.0% | -0.49 | EUR 1.87B | EUR 7.29B | EUR 12.03B |
| FY2022 | EUR 17.83B | -EUR 1.61B | -EUR 979.00M | 40.4% | -1.68 | EUR 1.17B | EUR 7.34B | EUR 13.25B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 23.69B | 18.1 | 4.2% | 1.01 |
| 2025 | 2025-12-31 | USD 25.76B | 25.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 23.42B | 13.8 | n/a | n/a |
| 2023 | 2023-12-29 | USD 22.04B | 12.7 | n/a | n/a |
| 2022 | 2022-12-30 | USD 14.34B | 8.1 | 6.4% | 0.96 |
| 2021 | 2021-12-31 | USD 34.64B | 20.0 | 2.8% | 1.03 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.01 USD, yield 4.1%.
| Year | Dividends/share |
|---|---|
| FY2022 | 0.96 EUR |
About Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Koninklijke Philips N.V. overvalued or undervalued?
Bullrun's valuation model currently marks Koninklijke Philips N.V. as 19.9% undervalued.
What is Koninklijke Philips N.V.'s market cap?
Koninklijke Philips N.V.'s market capitalization is USD 23.69B.
What is Koninklijke Philips N.V.'s P/E ratio?
Koninklijke Philips N.V.'s price-to-earnings (P/E) ratio is 18.1.
Does Koninklijke Philips N.V. pay a dividend?
Koninklijke Philips N.V. has a dividend yield of 4.1%.
What does Koninklijke Philips N.V. do?
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V.